Establishment Labs Holdings (ESTA) Prices 2.286M Share Common Offering at $26.25/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/29/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Needham sees mature node semiconductor strength in latest tracker
Establishment Labs Announces Pricing of Public Offering of Common Shares
January 29, 2020 10:50 PM ESTNEW YORK, Jan. 29, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the Company), a medical technology company focused on Womens Health initially in the breast aesthetics and reconstruction market today announced the pricing of its public offering of 2,285,714 common shares at $26.25 per share. The gross proceeds to Establishment Labs, before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $60.0 million. The offering is scheduled to close on February 3, 2020, subject to the satisfaction of customary closing conditions. In addition, the Company has granted the underwriters a 30-day... More
